Candesic

THE SCOOP

Small fish in a big pond

Small, efficient and practical are words that you might use to describe London-based consultancy Candesic.  The privately owned company is a boutique practice in every sense of the word, anchored around just fifteen experienced consultants.  This number doesn't limit its expertise, however, as the firm is able to draw on the experience of a pool of around 150 independent experts and consultants from affiliate companies across 21 different cities in Europe, North America, the Middle East and Asia Pacific.  Not a bad way to cut down on your overhead, especially when times are tough economically.  Candesic only pays these additional consultants when it needs them, either on a part-time or full-time basis, and tries to optimize the use of its office space.

With a decade of experience, the firm specialises in health care, aerospace, defence and security, technology and telecoms and private equity.  It also provides its services in education, financial services, food,  and fine and specialty chemicals industries. 

Punching above its weight

Candesic came into being in 2002 after the dot-com bubble had well and truly burst.  Seeing the financial bleed that was occurring throughout the markets, Dr Leonid Shapiro realized, while working for McKinsey, that consultancies that could provide their services at a lower cost would ultimately benefit from the instability in the economy.  Along with a crew of other McKinsey defectors, Shapiro set about the task of creating a firm that would provide services more economically than conventional top consultancies, thus appealing to smaller companies that might not have previously considered using the services of an outside party.  Today, Candesic has two partners who worked previously for McKinsey: Shapiro, who is both a medical doctor as well as a management consultant with experience in health care and technology; and Marc Kitten who leads the firm's continental development. Candesic works with a range of companies, from small independents to the bigger hitters in the Fortune 500.

The company quickly picked up an impressive array of international clients, and after two years of operation, it expanded its services further.  The first stage of this expansion was the opening of a branch in Paris to meet the demands of Candesic's increasingly large European client base, while the second stage saw the creation of a health care due diligence unit in London, aimed at companies involved in the medical sector.  By 2007, business was doing so well that it was time once again to expand Candesic's foothold in Europe, with the firm opening its third office, this time in Madrid.


A healthy dose of consultancy

Since opening its health care due diligence unit, Candesic has become an expert in the field.  The partners work alongside several medical doctors.  The consultancy looks at investments of between €10 million and €15 billion-typically in healthcare services medical technologies, later-stage biotech, and pharmaceutical spinoffs-and gives advice on acquisition strategy, European and US market entry strategy, research strategy and marketing to physicians.  

Candesic's knowledge of the aerospace & defence industry isn't to be sniffed, at either, with its consultants in this area boasting a combined working experience with half of the top-10 world players.  In addition, it works with a number of smaller private companies with international reach.



Everyone benefits

Candesic keeps costs down for its clients through its performance-based remuneration structure for consultants, in addition to only paying its affiliate experts if and when they work.  This not only benefits Candesic, but frees consultants to pick and choose jobs as they like, leading to a completely flexible working structure.  Plus, if clients aren't completely satisfied with a job, the consultants simply don't get paid.  This explains the firm's eagerness to evaluate the extent to which it feels it can help a client before agreeing to take on a project.  Candesic's partners and practice leaders oversee every potential engagement, along with a team of consultants from the relevant sectors, (both in-house and affiliate) and talk through the possible scenarios with the client.  If it is felt that the consultancy can benefit the client, then Candesic will press ahead with a proposed plan.  If not, the consultancy makes sure the process continues no further.

 

IN THE NEWS 

June 2014 

LBO of Ceva

Candesic advised CDH Investments, the pioneering China-based fund, who alongside Temasek of Singapore invested in Ceva Sante Animale's 4th LBO. With c.€700 million revenue in 2013, Ceva is among the top 10 global animal health businesses.

 

June 2014 

Health Investor awards

Candesic wins 'Strategy Consultancy of the year 2014' at Health Investor awards

 

January 2014 

Acquisition of the Complete Group by MITIE
Candesic advised the global facilities management firm MITIE on their continued investment in the healthcare industry to acquire one of the best known providers of high acuity home care in the UK.  Candesic performed both a clinical (leveraging its doctors) and commercial due diligence which led to specific management changes and strategic moves to drive quality and growth in the company.

 

November 2013 

Partial privatization of CLS Group in France

Candesic advised Ardian, formerly AXA Private Equity, in its investment to become the second shareholder in CLS behind French government agency CNES. CLS is a global provider of location services, environmental data collection, monitoring and ocean observation.

 

October 2013 

Post Merger Integration in petrochemicals

Candesic advised HIG Capital, a major LBO fund, on the merger integration of Haltermann GmbH (Germany) and Petrochem Carless Holdings Ltd (UK) into HCS, a leading producer of performance hydrocarbons, hydrocarbon specialties, and tailored hydrocarbon solvents and blends.

 

July 2013

Privatisation of Plasma Resources UK

Candesic advised the UK Department of Health on the sale of its Plasma Operations. Bain Capital subsequently acquired an 80 per cent share in the blood products company for £200m, with Department of Health retaining the remainder.

▲ Show Less▼ Show Full Description


Candesic


New Zealand House
80 Haymarket
London SW1Y 4TQ
Phone: +44 (0)20 7096 7680
Fax: +44 (0)20 7206 9383
www.candesic.com

STATS


  • Employer Type: Private
  • Founder & Partner: Dr. Leonid Shapiro
  • Founder & Partner: Marc Kitten
  • Partner: Dr. Michelle Tempest
  • 2014 Employees: 18

  • Employment Contact

    Applicants can submit their CV to talent@candesic.com

     


  • Major Departments & Practices

    Aerospace, Defence and Security

    Financial Services

    Health Care

    Private Equity

    Technology and Telecom

Major Office Locations

  • London
  • Madrid
    Paris
    Affiliate network in 21 countries

Career Update Newsletter

Tips and tools to help you manage your ideal career.